Follow
Benjamin Howden
Benjamin Howden
Professor and Director, Microbiological Diagnostic Unit, University of Melbourne at The Doherty
Verified email at unimelb.edu.au - Homepage
Title
Cited by
Cited by
Year
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains …
BP Howden, JK Davies, PDR Johnson, TP Stinear, ML Grayson
Clinical microbiology reviews 23 (1), 99-139, 2010
10942010
Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility
BP Howden, PB Ward, PGP Charles, TM Korman, A Fuller, P Du Cros, ...
Clinical Infectious Diseases 38 (4), 521-528, 2004
5692004
Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
PGP Charles, PB Ward, PDR Johnson, BP Howden, ML Grayson
Clinical infectious diseases 38 (3), 448-451, 2004
4542004
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
BP Howden, CRE McEvoy, DL Allen, K Chua, W Gao, PF Harrison, J Bell, ...
PLoS pathogens 7 (11), e1002359, 2011
2952011
Whole genome sequencing in clinical and public health microbiology
JC Kwong, N McCallum, V Sintchenko, BP Howden
Pathology 47 (3), 199-210, 2015
2822015
Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia
L Caly, J Druce, J Roberts, K Bond, T Tran, R Kostecki, Y Yoga, ...
Medical Journal of Australia 212 (10), 459-462, 2020
2622020
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ...
Journal of Infectious Diseases 204 (3), 340-347, 2011
2592011
Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
BP Howden, PDR Johnson, PB Ward, TP Stinear, JK Davies
Antimicrobial Agents and Chemotherapy 50 (9), 3039-3047, 2006
2542006
Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand
JD Turnidge, D Kotsanas, W Munckhof, S Roberts, CM Bennett, ...
Medical Journal of Australia 191 (7), 368-373, 2009
2462009
Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection
W Gao, K Chua, JK Davies, HJ Newton, T Seemann, PF Harrison, ...
PLoS pathogens 6 (6), e1000944, 2010
2212010
Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns
DA Williamson, GP Carter, BP Howden
Clinical microbiology reviews 30 (3), 827-860, 2017
2202017
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine
BP Howden, MA Slavin, AP Schwarer, AM Mijch
European Journal of Clinical Microbiology and Infectious Diseases 22 (2 …, 2003
2142003
Dumb and Dumber—The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus aureus
BP Howden, ML Grayson
Clinical Infectious Diseases 42 (3), 394-400, 2006
2082006
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia
NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ...
Antimicrobial agents and chemotherapy 57 (4), 1654-1663, 2013
2042013
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
A Poudyal, BP Howden, JM Bell, W Gao, RJ Owen, JD Turnidge, ...
Journal of Antimicrobial Chemotherapy 62 (6), 1311-1318, 2008
2012008
Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study
KS Baker, TJ Dallman, PM Ashton, M Day, G Hughes, PD Crook, ...
The Lancet infectious diseases 15 (8), 913-921, 2015
1932015
Prospective whole-genome sequencing enhances national surveillance of Listeria monocytogenes
JC Kwong, K Mercoulia, T Tomita, M Easton, HY Li, DM Bulach, ...
Journal of clinical microbiology 54 (2), 333-342, 2016
1892016
Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients
E Bishop, S Melvani, BP Howden, PGP Charles, ML Grayson
Antimicrobial agents and chemotherapy 50 (4), 1599-1602, 2006
1882006
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis
JYH Lee, IR Monk, A Gonçalves da Silva, T Seemann, KYL Chua, ...
Nature microbiology 3 (10), 1175-1185, 2018
1592018
Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA-its evolving antimicrobial …
K Chua, F Laurent, G Coombs, ML Grayson, BP Howden
Clinical infectious diseases: an official publication of the Infectious …, 2011
1592011
The system can't perform the operation now. Try again later.
Articles 1–20